Yang-Xin Fu

50PUBLICATIONS
167CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Electrical circuits and systemsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Jun 02, 2026
Targeting tumor-specific T cells with LAG3-directed interleukin-2 prevents T-cell exhaustion and reinvigorates antitumor immunity.

|Apr 22, 2026
Selective elimination of circulating effector CD8 T cells via LTβR blockade separates anti-CD137 efficacy from toxicity.

|Apr 16, 2026
Reprogramming the tumor microenvironment with antibody against membrane-proximal AXL to overcome immune checkpoint blockade resistance.

|Mar 18, 2026
Reactivating exhausted tumor-infiltrating T cells by a bispecific DC-T cell engager in mice.

Xuhao Zhang, Yu Gao, Wenbo Hu

|Jan 04, 2026
Opportunities and challenges of targeting cGAS-STING in cancer.

Changzheng Lu, Wenyan Wang, Yang-Xin Fu

|Oct 10, 2025
A next-generation anti-CTLA-4 probody mitigates toxicity and enhances anti-tumor immunity in mice.

Weian Cao, Junfan Chen, Yutong Fu

Pageof 9

Frequent Collaborators

11 joint publications

Hua Peng

6 joint publications

Wenyan Wang

4 joint publications

Zhichen Sun

3 joint publications

Yong Liang